相关实验视频

Updated: Jul 11, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K

在第三阶段非小细胞肺癌中杜尔瓦卢马布的结果:单一机构研究

Jonathan Q Trinh1, Ying Xiong2, Lynette M Smith2

  • 1Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, U.S.A.; jtrinh@unmc.edu.

Anticancer research
|February 2, 2024
PubMed
概括

化学放射治疗后的杜尔瓦卢马布整合疗法在现实数据中显著改善了不可切除的第三阶段非小细胞肺癌 (NSCLC) 患者的生存率. 无论治疗时间,PD-L1状态或中性粒细胞与淋巴细胞的比率如何,结果都是积极的.

关键词:
在PD-L1中.第三阶段非小细胞肺癌达尔瓦卢马布 (Durvalumab) 是一种耐药的药物.免疫疗法 免疫疗法中性粒细胞与淋巴细胞的比率.

更多相关视频

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

10.6K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.9K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...